These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25340426)

  • 1. Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.
    Nelson HS
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1437-51. PubMed ID: 25340426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.
    Dranitsaris G; Ellis AK
    J Eval Clin Pract; 2014 Jun; 20(3):225-38. PubMed ID: 24444390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE; Calderon M; Milani M
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.
    Maloney J; Berman G; Gagnon R; Bernstein DI; Nelson HS; Kleine-Tebbe J; Kaur A; Li Q; Nolte H
    J Allergy Clin Immunol Pract; 2016; 4(2):301-9.e2. PubMed ID: 26755098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
    Durham SR; Creticos PS; Nelson HS; Li Z; Kaur A; Meltzer EO; Nolte H
    J Allergy Clin Immunol; 2016 Oct; 138(4):1081-1088.e4. PubMed ID: 27527264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
    Creticos PS; Gunaydin FE; Nolte H; Damask C; Durham SR
    J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1415-1427. PubMed ID: 38685477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study.
    Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B
    J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.
    Bernstein DI; Bardelas JA; Svanholm Fogh B; Kaur A; Li Z; Nolte H
    Postgrad Med; 2017 Aug; 129(6):590-597. PubMed ID: 28326906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials.
    Halken S; Roberts G; Valovirta E; Nolte H; Hulstrøm V; Blaiss MS
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1387-1393.e2. PubMed ID: 31954191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
    Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
    Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.
    Brunton S; Nelson HS; Bernstein DI; Lawton S; Lu S; Nolte H
    Postgrad Med; 2017 Aug; 129(6):581-589. PubMed ID: 28326908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy: current concepts for the U.S. practitioner.
    Lin SY
    Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S55-9. PubMed ID: 25182357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations in the use of sublingual immunotherapy for allergic rhinitis.
    Lee S; Nolte H; Benninger MS
    Am J Rhinol Allergy; 2015; 29(2):106-14. PubMed ID: 25785750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.
    Passalacqua G; Canonica GW; Bagnasco D
    Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study.
    Reiber R; Keller M; Keller W; Wolf H; Schnitker J; Wüstenberg E
    Clin Transl Allergy; 2015; 6():9. PubMed ID: 26958338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in allergen immunotherapy.
    Vadlamudi A; Shaker M
    Curr Opin Pediatr; 2015 Oct; 27(5):649-55. PubMed ID: 26241500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.